Valuation Update With 7 Day Price Move • May 13
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥12.07, the stock trades at a trailing P/E ratio of 27.5x. Average trailing P/E is 44x in the Medical Equipment industry in China. Total returns to shareholders of 8.1% over the past three years. Reported Earnings • Apr 28
Full year 2025 earnings released: EPS: CN¥0.40 (vs CN¥0.59 in FY 2024) Full year 2025 results: EPS: CN¥0.40 (down from CN¥0.59 in FY 2024). Revenue: CN¥3.67b (up 10% from FY 2024). Net income: CN¥248.9m (down 33% from FY 2024). Profit margin: 6.8% (down from 11% in FY 2024). Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 7% per year. Announcement • Apr 28
Allmed Medical Products Co.,Ltd, Annual General Meeting, May 20, 2026 Allmed Medical Products Co.,Ltd, Annual General Meeting, May 20, 2026, at 14:30 China Standard Time. Location: No. 247, Jinxing Middle Road, Yuelu District, Changsha, Hunan China Buy Or Sell Opportunity • Apr 15
Now 22% undervalued Over the last 90 days, the stock has risen 18% to CN¥13.86. The fair value is estimated to be CN¥17.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.4% over the last 3 years. Earnings per share has grown by 6.3%. New Risk • Apr 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 31% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.1% average weekly change). Valuation Update With 7 Day Price Move • Apr 10
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥13.56, the stock trades at a trailing P/E ratio of 18.5x. Average trailing P/E is 39x in the Medical Equipment industry in China. Total returns to shareholders of 17% over the past three years. Announcement • Mar 31
Allmed Medical Products Co.,Ltd to Report Q1, 2026 Results on Apr 28, 2026 Allmed Medical Products Co.,Ltd announced that they will report Q1, 2026 results on Apr 28, 2026 Valuation Update With 7 Day Price Move • Mar 19
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥12.04, the stock trades at a trailing P/E ratio of 16.5x. Average trailing P/E is 41x in the Medical Equipment industry in China. Negligible returns to shareholders over past three years. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to CN¥10.46, the stock trades at a trailing P/E ratio of 14.3x. Average trailing P/E is 42x in the Medical Equipment industry in China. Total loss to shareholders of 15% over the past three years. Announcement • Dec 31
Allmed Medical Products Co.,Ltd to Report Fiscal Year 2025 Results on Apr 28, 2026 Allmed Medical Products Co.,Ltd announced that they will report fiscal year 2025 results on Apr 28, 2026 Announcement • Nov 13
Allmed Medical Products Co.,Ltd Approves Board Elections Allmed Medical Products Co.,Ltd announced at first extraordinary general meeting of 2025 held on 11 November 2025, the shareholders elected Cui Hui, Cui Xingwei and Wu Jiayue as non-independent directors of the company. Valuation Update With 7 Day Price Move • Nov 07
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥12.71, the stock trades at a trailing P/E ratio of 17.4x. Average trailing P/E is 40x in the Medical Equipment industry in China. Total returns to shareholders of 7.6% over the past three years. Reported Earnings • Oct 30
Third quarter 2025 earnings released: EPS: CN¥0.24 (vs CN¥0.13 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.24 (up from CN¥0.13 in 3Q 2024). Revenue: CN¥920.3m (up 6.0% from 3Q 2024). Net income: CN¥149.0m (up 91% from 3Q 2024). Profit margin: 16% (up from 9.0% in 3Q 2024). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Announcement • Sep 30
Allmed Medical Products Co.,Ltd to Report Q3, 2025 Results on Oct 30, 2025 Allmed Medical Products Co.,Ltd announced that they will report Q3, 2025 results on Oct 30, 2025 Reported Earnings • Aug 27
Second quarter 2025 earnings released: EPS: CN¥0.18 (vs CN¥0.15 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.18 (up from CN¥0.15 in 2Q 2024). Revenue: CN¥917.7m (up 9.9% from 2Q 2024). Net income: CN¥113.3m (up 22% from 2Q 2024). Profit margin: 12% (up from 11% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 6% per year. Buy Or Sell Opportunity • Aug 14
Now 21% undervalued Over the last 90 days, the stock has risen 13% to CN¥9.74. The fair value is estimated to be CN¥12.29, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.9% over the last 3 years. Earnings per share has declined by 22%. Announcement • Jul 02
Allmed Medical Products Co.,Ltd to Report First Half, 2025 Results on Aug 27, 2025 Allmed Medical Products Co.,Ltd announced that they will report first half, 2025 results on Aug 27, 2025 Declared Dividend • Jun 15
Dividend increased to CN¥0.06 Dividend of CN¥0.06 is 122% higher than last year. Ex-date: 19th June 2025 Payment date: 19th June 2025 Dividend yield will be 0.7%, which is lower than the industry average of 2.2%. Sustainability & Growth Dividend is well covered by both earnings (10% earnings payout ratio) and cash flows (7% cash payout ratio). The dividend has decreased over the past 66 years, indicating a lack of growth and stability in payments. Earnings per share has remained steady over the last 5 years. Unless this trend deteriorates, it should provide adequate earnings cover for the dividend. Reported Earnings • Apr 28
First quarter 2025 earnings released: EPS: CN¥0.14 (vs CN¥0.15 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.14 (down from CN¥0.15 in 1Q 2024). Revenue: CN¥758.7m (up 1.6% from 1Q 2024). Net income: CN¥86.5m (down 7.9% from 1Q 2024). Profit margin: 11% (down from 13% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Announcement • Apr 26
Allmed Medical Products Co.,Ltd, Annual General Meeting, May 29, 2025 Allmed Medical Products Co.,Ltd, Annual General Meeting, May 29, 2025, at 14:30 China Standard Time. Location: The Company Headquarters' Meeting Room, Zhijiang, Hubei China Valuation Update With 7 Day Price Move • Apr 08
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥7.79, the stock trades at a trailing P/E ratio of 21.5x. Average trailing P/E is 28x in the Medical Equipment industry in China. Total loss to shareholders of 34% over the past three years. Announcement • Mar 31
Allmed Medical Products Co.,Ltd to Report Q1, 2025 Results on Apr 28, 2025 Allmed Medical Products Co.,Ltd announced that they will report Q1, 2025 results on Apr 28, 2025 Announcement • Jan 24
Allmed Medical Products Co.,Ltd (SZSE:002950) announces an Equity Buyback for CNY 100 million worth of its shares. Allmed Medical Products Co.,Ltd (SZSE:002950) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million. The shares will be purchased at a price not exceeding CNY 11 per share. The repurchased shares will be used for the implementation of ESOP or equity incentive plan. The repurchases will be funded from own funds. Purpose of the proposed share repurchase: intended to be used for equity incentives or employee stock ownership plans. The program will be valid for 12 months. Announcement • Dec 31
Allmed Medical Products Co.,Ltd to Report Fiscal Year 2024 Results on Apr 26, 2025 Allmed Medical Products Co.,Ltd announced that they will report fiscal year 2024 results on Apr 26, 2025 Valuation Update With 7 Day Price Move • Nov 22
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to CN¥10.08, the stock trades at a trailing P/E ratio of 27.8x. Average trailing P/E is 37x in the Medical Equipment industry in China. Total loss to shareholders of 25% over the past three years. Reported Earnings • Oct 31
Third quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.01 loss in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.13 (up from CN¥0.01 loss in 3Q 2023). Revenue: CN¥868.4m (up 47% from 3Q 2023). Net income: CN¥78.2m (up CN¥84.8m from 3Q 2023). Profit margin: 9.0% (up from net loss in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings. Announcement • Sep 30
Allmed Medical Products Co.,Ltd to Report Q3, 2024 Results on Oct 31, 2024 Allmed Medical Products Co.,Ltd announced that they will report Q3, 2024 results on Oct 31, 2024 Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to CN¥8.60, the stock trades at a trailing P/E ratio of 38x. Average trailing P/E is 31x in the Medical Equipment industry in China. Total loss to shareholders of 31% over the past three years. Buy Or Sell Opportunity • Sep 24
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 7.7% to CN¥7.30. The fair value is estimated to be CN¥5.91, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 46%. Buy Or Sell Opportunity • Sep 02
Now 25% overvalued Over the last 90 days, the stock has fallen 5.6% to CN¥7.37. The fair value is estimated to be CN¥5.90, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 46%. Reported Earnings • Aug 31
Second quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.046 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.15 (up from CN¥0.046 in 2Q 2023). Revenue: CN¥835.2m (up 37% from 2Q 2023). Net income: CN¥93.1m (up 219% from 2Q 2023). Profit margin: 11% (up from 4.8% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings. Announcement • Jun 29
Allmed Medical Products Co.,Ltd to Report First Half, 2024 Results on Aug 31, 2024 Allmed Medical Products Co.,Ltd announced that they will report first half, 2024 results on Aug 31, 2024 Declared Dividend • Jun 14
Dividend reduced to CN¥0.027 Dividend of CN¥0.027 is 55% lower than last year. Ex-date: 19th June 2024 Payment date: 19th June 2024 Dividend yield will be 0.4%, which is lower than the industry average of 2.2%. Sustainability & Growth Dividend is well covered by both earnings (22% earnings payout ratio) and cash flows (4% cash payout ratio). The dividend has decreased over the past 56 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to decline by 75% to shift the payout ratio to a potentially unsustainable range, which is more than the 22% EPS decline seen over the last 5 years. Buy Or Sell Opportunity • May 21
Now 21% undervalued Over the last 90 days, the stock has risen 14% to CN¥8.33. The fair value is estimated to be CN¥10.50, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.4% over the last 3 years. Earnings per share has declined by 55%. Announcement • May 02
Allmed Medical Products Co.,Ltd Proposes Final Cash Dividend for 2023 Allmed Medical Products Co.,Ltd proposed final cash dividend of CNY 0.27000000 per ten shares (tax included) for the year 2023. Announcement • May 01
Allmed Medical Products Co.,Ltd, Annual General Meeting, May 24, 2024 Allmed Medical Products Co.,Ltd, Annual General Meeting, May 24, 2024, at 14:30 China Standard Time. Location: The Company Headquarters' Meeting Room, Zhijiang, Hubei China Reported Earnings • Apr 30
First quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.20 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.15 (down from CN¥0.20 in 1Q 2023). Revenue: CN¥746.4m (down 8.4% from 1Q 2023). Net income: CN¥93.9m (down 27% from 1Q 2023). Profit margin: 13% (down from 16% in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings. Announcement • Mar 30
Allmed Medical Products Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024 Allmed Medical Products Co.,Ltd announced that they will report Q1, 2024 results on Apr 30, 2024 Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥7.09, the stock trades at a trailing P/E ratio of 12.5x. Average trailing P/E is 26x in the Medical Equipment industry in China. Total loss to shareholders of 60% over the past three years. Announcement • Dec 29
Allmed Medical Products Co.,Ltd to Report Fiscal Year 2023 Results on Apr 30, 2024 Allmed Medical Products Co.,Ltd announced that they will report fiscal year 2023 results on Apr 30, 2024 Reported Earnings • Nov 01
Third quarter 2023 earnings released: CN¥0.01 loss per share (vs CN¥0.15 loss in 3Q 2022) Third quarter 2023 results: CN¥0.01 loss per share (improved from CN¥0.15 loss in 3Q 2022). Revenue: CN¥591.6m (down 37% from 3Q 2022). Net loss: CN¥6.63m (loss narrowed 93% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 30
Second quarter 2023 earnings released: EPS: CN¥0.046 (vs CN¥0.21 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.046 (down from CN¥0.21 in 2Q 2022). Revenue: CN¥612.1m (down 46% from 2Q 2022). Net income: CN¥29.2m (down 78% from 2Q 2022). Profit margin: 4.8% (down from 12% in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 29% per year, which means it has not declined as severely as earnings. Announcement • Jun 08
Allmed Medical Products Co., Ltd Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 14, 2023 Allmed Medical Products Co. Ltd. announced final cash dividend of CNY 0.60 per 10 shares on A shares for the year 2022. Record date is June 13, 2023, Ex-Date is June 14, 2023 and Payment Date is June 14, 2023. Reported Earnings • Apr 30
First quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.25 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.20 (down from CN¥0.25 in 1Q 2022). Revenue: CN¥814.6m (down 18% from 1Q 2022). Net income: CN¥127.9m (down 19% from 1Q 2022). Profit margin: 16% (in line with 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings. Reported Earnings • Oct 31
Third quarter 2022 earnings released: CN¥0.15 loss per share (vs CN¥0.14 profit in 3Q 2021) Third quarter 2022 results: CN¥0.15 loss per share (down from CN¥0.14 profit in 3Q 2021). Revenue: CN¥932.7m (up 12% from 3Q 2021). Net loss: CN¥93.2m (down 202% from profit in 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 4% per year. Announcement • Oct 02
Allmed Medical Products Co., Ltd Announces Board Elections Allmed Medical Products Co. Ltd. announced that at its EGM held on September 29, 2022, shareholders approved the election of Cui Dongning as non-independent directors, Cai Manli, Tan Guangjun and Cai Tianzhi as independent directors and Feng Shihai and Yang Xiumei as non-employee supervisors. Valuation Update With 7 Day Price Move • Jul 22
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥13.95, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 32x in the Medical Equipment industry in China. Total returns to shareholders of 4.2% over the past three years. Announcement • Jun 02
Allmed Medical Products Co., Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on June 9, 2022 Allmed Medical Products Co. Ltd. announced 2021 final profit distribution plan to be implemented (A shares), payable on June 9, 2022. The company announced Cash dividend/10 shares (tax included) of CNY 2.10000000. The record date is June 8, 2022 and ex-date is June 9, 2022. Announcement • May 24
Allmed Medical Products Co., Ltd Approves Cash Dividend for the Year 2021 Allmed Medical Products Co. Ltd. announced that at its Annual General Meeting of 2021 held on 20 May 2022, approved Cash dividend/10 shares (tax included) of CNY 2.10000000 for the year 2021. Announcement • Apr 27
Allmed Medical Products Co., Ltd Proposes Final Dividend for 2021 Allmed Medical Products Co. Ltd. announced on 26 April 2022 the profit distribution proposal for 2021 as follows: Cash dividend/10 shares (tax included) of CNY 2.10000000. Reported Earnings • Apr 27
Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2021 results: EPS: CN¥0.68 (down from CN¥1.83 in FY 2020). Revenue: CN¥2.93b (down 24% from FY 2020). Net income: CN¥431.2m (down 63% from FY 2020). Profit margin: 15% (down from 30% in FY 2020). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 3.3%. Earnings per share (EPS) exceeded analyst estimates by 4.5%. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Board Change • Apr 27
High number of new directors There are 7 new directors who have joined the board in the last 3 years. Non-Independent Director Wenjian Huang was the last director to join the board, commencing their role in 2019. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Buying Opportunity • Jan 21
Now 25% undervalued Over the last 90 days, the stock is up 10%. The fair value is estimated to be CN¥19.90, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% per annum over the last 3 years. Earnings per share has grown by 45% per annum over the last 3 years. Valuation Update With 7 Day Price Move • Dec 30
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥15.70, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 41x in the Medical Equipment industry in China. Total loss to shareholders of 19% over the past year. Reported Earnings • Oct 31
Third quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.39 in 3Q 2020) The company reported a poor third quarter result with weaker earnings and profit margins, although revenues were flat. Third quarter 2021 results: Revenue: CN¥830.7m (flat on 3Q 2020). Net income: CN¥91.4m (down 63% from 3Q 2020). Profit margin: 11% (down from 30% in 3Q 2020). Reported Earnings • Aug 30
Second quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.98 in 2Q 2020) The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥676.0m (down 59% from 2Q 2020). Net income: CN¥121.5m (down 80% from 2Q 2020). Profit margin: 18% (down from 37% in 2Q 2020). The decrease in margin was driven by lower revenue. Valuation Update With 7 Day Price Move • Aug 03
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥16.01, the stock trades at a trailing P/E ratio of 8.6x. Average trailing P/E is 39x in the Medical Equipment industry in China. Total loss to shareholders of 46% over the past year. Announcement • May 28
Allmed Medical Products Co., Ltd Approves Dividend for the Year 2020 Allmed Medical Products Co. Ltd. announced at the AGM held on May 25, 2021 that the company approved Cash dividend/10 shares (tax included) of CNY 8.80000000. Valuation Update With 7 Day Price Move • Apr 27
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥22.25, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 42x in the Medical Equipment industry in China. Total returns to shareholders of 5.8% over the past year. Reported Earnings • Apr 17
Full year 2020 earnings released: EPS CN¥1.83 (vs CN¥0.53 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥3.83b (up 63% from FY 2019). Net income: CN¥1.16b (up 255% from FY 2019). Profit margin: 30% (up from 14% in FY 2019). The increase in margin was driven by higher revenue. Is New 90 Day High Low • Mar 09
New 90-day low: CN¥18.29 The company is down 15% from its price of CN¥21.50 on 09 December 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is down 3.0% over the same period. Announcement • Mar 09
Allmed Medical Products Co., Ltd to Report Fiscal Year 2020 Results on Apr 16, 2021 Allmed Medical Products Co., Ltd announced that they will report fiscal year 2020 results on Apr 16, 2021 Is New 90 Day High Low • Feb 04
New 90-day low: CN¥19.12 The company is down 17% from its price of CN¥23.10 on 06 November 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 3.0% over the same period. Is New 90 Day High Low • Dec 29
New 90-day low: CN¥20.20 The company is down 18% from its price of CN¥24.49 on 30 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 4.0% over the same period. Is New 90 Day High Low • Dec 11
New 90-day low: CN¥20.70 The company is down 17% from its price of CN¥24.89 on 11 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 1.0% over the same period. Is New 90 Day High Low • Nov 11
New 90-day low: CN¥22.50 The company is down 19% from its price of CN¥27.81 on 13 August 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is down 4.0% over the same period. Announcement • Nov 04
Allmed Medical Products Co., Ltd (SZSE:002950) agreed to acquire 10% stake in Sichuan Zhenghexiang Health Pharmacy Chain Co., Ltd. from Chen Weixing, Guanghan Zhenghe Zhirong Medical Technology Service Center (Limited Partnership), Guanghan Zhenghe Zhijing Medical Technology Service Center (Limited Partnership), Zhao Xin and Kuang Zhibin for CNY 230 million. Allmed Medical Products Co., Ltd (SZSE:002950) agreed to acquire 10% stake in Sichuan Zhenghexiang Health Pharmacy Chain Co., Ltd. from Chen Weixing, Guanghan Zhenghe Zhirong Medical Technology Service Center (Limited Partnership), Guanghan Zhenghe Zhijing Medical Technology Service Center (Limited Partnership), Zhao Xin and Kuang Zhibin for CNY 230 million on October 29, 2020. Within 60 working days from the effective date of this agreement, the sellers are responsible for signing an equity transfer agreement with the company through their respective established holding platform, going through the equity delivery procedures, and completing the transfer of 10% stake in the target to the company, corresponding to a capital contribution of CNY 10.01 million. Within 10 working days from the date of completion of the above transaction step, the target company and related shareholders will sign a capital increase agreement with the company, and go through the settlement procedures for the capital increase, and the company will commit to carry out a capital increase in the target company. After the completion of the first transaction and the second transaction, the company will finally obtain no less than 14.75% stake in the target company. As at June July 31, 2020, Sichuan Zhenghexiang had total assets of CNY 917.19 million and net assets of CNY 275.46 million. On October 29, 2020, the 15th session of the Allmed Medical's 2nd Directorate approved the proposal on the acquisition of equity and capital increase in Sichuan Zhenghexiang. Is New 90 Day High Low • Oct 27
New 90-day low: CN¥24.19 The company is down 18% from its price of CN¥29.50 on 29 July 2020. The Chinese market is flat over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is down 6.0% over the same period. Reported Earnings • Oct 26
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥1.07b, up 250% from the prior year. Total revenue was CN¥3.73b over the last 12 months, up 63% from the prior year. Reported Earnings • Oct 23
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥1.07b, up 250% from the prior year. Total revenue was CN¥3.73b over the last 12 months, up 63% from the prior year. Announcement • Oct 17
Allmed Medical Products Co., Ltd to Report Q3, 2020 Results on Oct 23, 2020 Allmed Medical Products Co., Ltd announced that they will report Q3, 2020 results on Oct 23, 2020 Announcement • Jul 24
Allmed Medical Products Co., Ltd to Report First Half, 2020 Results on Aug 20, 2020 Allmed Medical Products Co., Ltd announced that they will report first half, 2020 results on Aug 20, 2020